FrancophonIA/ELRC3.0 huggingface dataset:
English: • Levetiracetam Teva is used as a chronic treatment.
Slovenian: • Zdravilo Levetiracetam Teva se uporablja za dolgotrajno zdravljenje.
English: • Levetiracetam Teva is not indicated in children and adolescents below 16 years on its own (monotherapy).
Slovenian: • Zdravilo Levetiracetam Teva pri otrocih in mladostnikih, mlajših od 16 let, ni indicirano za samostojno zdravljenje (monoterapija).
English: The maximum dose is 1500 mg twice daily.
Slovenian: Največji odmerek je 1500 mg dvakrat na dan.
English: • Dose in infants (1 month to 23 months), children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg:
Slovenian: • Odmerjanje pri dojenčkih (od 1 meseca do 23 mesecev), otrocih (od 2 do 11 let) in mladostnikih (od 12 do 17 let), lažjih od 50 kg:
English: Each Levetiracetam Teva 250, 500, 750, 1,000 mg film-coated tablet contains 250, 500, 750, 1,000 mg levetiracetam.
Slovenian: Ena 250, 500, 750, 1.000 mg filmsko obložena tableta zdravila Levetiracetam Teva vsebuje 250, 500, 750, 1.000 mg levetiracetama.
English: The fractional removal of levetiracetam was 51 % during a typical 4-hour dialysis session.
Slovenian: Frakcijska odstranitev levetiracetama med tipično 4-urno dializo je bila 51 %.
English: The tablet formulation is not adapted for use in infants and children under the age of 6 years.
Slovenian: Farmacevtska oblika tableta ni primerna za uporabo pri dojenčkih in otrocih, mlajših od 6 let.
English: If stopping treatment, Levetiracetam Teva should be discontinued gradually to avoid an increase of seizures.
Slovenian: Pri zdravilu Levetiracetam Teva je treba zdravljenje opustiti postopoma, da se število napadov ne bi povečalo.
English: • as an add-on to other antiepileptic medicines to treat: ■ partial onset seizures with or without generalisation in adults, adolescents, children and infants from one month of age ■ myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy ■ primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Slovenian: ■ parcialnih napadov z generalizacijo ali brez nje pri odraslih, mladostnikih, otrocih in dojenčkih od 1 meseca dalje ■ miokloničnih napadov (kratki, nenadni trzaji mišice ali skupine mišic) pri odraslih in mladostnikih od 12. leta starosti z juvenilno mioklonično epilepsijo ■ primarno generaliziranih tonično-kloničnih napadov (veliki napadi, vključno z izgubo zavesti) pri odraslih in mladostnikih od 12. leta starosti z idiopatsko generalizirano epilepsijo (oblika epilepsije, za katero se domneva, da je genetskega izvora)
English: As in adults, there is no evidence of clinically significant medicinal product interactions in paediatric patients receiving up to 60 mg/kg/day levetiracetam.
Slovenian: Tako kot pri odraslih tudi pri pediatričnih bolnikih, ki so prejemali do 60 mg/kg/dan levetiracetama, ni jasnih dokazov o klinično značilnem medsebojnem delovanju z zdravili.
English: In this study, levetiracetam dose was 3000 mg/day for adults and adolescents or 60 mg/kg/day for children, given in 2 divided doses.
Slovenian: V tej študiji je bil odmerek levetiracetama za odrasle in mladostnike 3.000 mg na dan, za otroke pa 60 mg/kg/dan, razdeljen na dva odmerka.
English: Therefore, there is no need for plasma level monitoring of levetiracetam.
Slovenian: Koncentracije levetiracetama v plazmi zato ni treba kontrolirati.
English: If you stop taking Levetiracetam Teva
Slovenian: Če ste prenehali jemati zdravilo Levetiracetam Teva
English: Levetiracetam efficacy was established in a 24-week double-blind, placebo-controlled study which included adults, adolescents and a limited number of children suffering from idiopathic generalized epilepsy with primary generalized tonic-clonic (PGTC) seizures in different syndromes (juvenile myoclonic epilepsy, juvenile absence epilepsy, childhood absence epilepsy, or epilepsy with Grand Mal seizures on awakening).
Slovenian: Učinkovitost levetiracetama je bila dokazana v 24-tedenski dvojno slepi, s placebom nadzorovani študiji, ki je vključevala odrasle, mladostnike in omejeno število otrok z idiopatsko generalizirano epilepsijo s primarno generaliziranimi tonično-kloničnimi (PGTC) napadi pri različnih sindromih (juvenilna mioklonična epilepsija, juvenilna epilepsija z absencami, otroška epilepsija z absencami ali epilepsija z grand mal napadi pri prebujanju).
English: In vitro, levetiracetam and its primary metabolite have been shown not to inhibit the major human liver cytochrome P450 isoforms (CYP3A4, 2A6, 2C9, 2C19, 2D6, 2E1 and 1A2), glucuronyl transferase (UGT1A1 AND UGT1A6) and epoxide hydroxylase activities.
Slovenian: In vitro so pokazali, da levetiracetam in njegov primarni presnovek ne zavirata aktivnosti glavnih izooblik človeškega jetrnega citokroma P450 (CYP3A4, 2A6, 2C9, 2C19, 2D6, 2E1 in 1A2),
English: CLcr (ml/min/1.73 m2) = CLcr (ml/min)__ x 1.73
Slovenian: CLcr (ml/min/1,73 m2) = CLcr (ml/min) x 1,73 BSA bolnika (m2)
English: For adult patients, refer to the following table and adjust the dose as indicated.
Slovenian: Sklicujoč se na spodnjo preglednico se odmerek za odrasle bolnike prilagodi kot je navedeno.
English: For children with renal impairment, levetiracetam dose needs to be adjusted based on the renal function as levetiracetam clearance is related to renal function.
Slovenian: Pri otrocih z ledvično okvaro je treba odmerek levetiracetama prilagoditi glede na delovanje ledvic,
English: The volume of distribution of levetiracetam is approximately 0.5 to 0.7 l/kg, a value close to the total body water volume.
Slovenian: Tako levetiracetam kot njegov primarni presnovek se ne vežeta pomembno na beljakovine v plazmi Volumen porazdelitve levetiracetama je približno 0,5 do 0,7 l/kg, kar je blizu vrednosti celotnega volumna vode v telesu.
English: Efficacy of levetiracetam as monotherapy was established in a double-blind, parallel group, non-inferiority comparison to carbamazepine controlled release (CR) in 576 patients 16 years of age or older with newly or recently diagnosed epilepsy.
Slovenian: Učinkovitost levetiracetama za samostojno zdravljenje je bila dokazana v dvojno slepi študiji z vzporednimi skupinami, ki dokazuje, da levetiracetam po učinkovitosti ni nič slabši od karbamazepina z nadzorovanim sproščanjem (CR), pri 576 bolnikih, starih 16 let ali več, z na novo ali nedavno diagnosticirano epilepsijo.
English: Infection
Slovenian: • okužba
English: (4)Following dialysis, a 3.5 to 7 mg/kg supplemental dose is recommended.
Slovenian: (4)Po dializi je priporočljiv dodatni odmerek od 3,5 do 7 mg/kg.
English: Tablet core: maize starch, povidone, croscarmellose sodium and magnesium stearate.
Slovenian: Jedro tablete: koruzni škrob, povidon, premreženi natrijev karmelozat in magnezijev stearat.
English: The possible side effects of an overdose of Levetiracetam Teva are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.
Slovenian: Možni neželeni učinki pri prevelikem odmerjanju zdravila Levetiracetam Teva so zaspanost, agitiranost, agresivnost, zmanjšana budnost, upočasnitev dihanja in koma.
English: There have been isolated reports of decreased levetiracetam efficacy when the osmotic laxative macrogol has been concomitantly administered with oral levetiracetam.
Slovenian: Obstajajo posamezna poročila o zmanjšani učinkovitosti levetiracetama pri sočasni uporabi makrogola, ki je osmotsko odvajalo, in peroralnega levetiracetama.
English: Levetiracetam Teva is used:
Slovenian: Zdravilo Levetiracetam Teva se uporablja:
English: 10 to 20 mg/kg once daily (3) (5)
Slovenian: 10 do 20 mg/kg enkrat na dan (3) (5)
English: Levetiracetam efficacy was established in a double-blind, placebo-controlled study of 16 weeks duration, in patients 12 years of age and older suffering from idiopathic generalized epilepsy with myoclonic seizures in different syndromes.
Slovenian: Učinkovitost levetiracetama je bila dokazana v dvojno slepi, s placebom nadzorovani 16-tedenski študiji pri bolnikih od 12 leta starosti, z idiopatsko generalizirano epilepsijo z miokloničnimi napadi pri različnih sindromih.
English: Four embryo-foetal development studies were performed in rabbits covering doses of 200, 600, 800, 1200 and 1800 mg/kg/day.
Slovenian: Štiri študije embriofetalnega razvoja pri kuncih so izvedli z odmerk 200, 600, 800, 1200 in
English: (5)Following dialysis, a 5 to 10 mg/kg supplemental dose is recommended.
Slovenian: (5)Po dializi je priporočljiv dodatni odmerek od 5 do 10 mg/kg.
English: Pack sizes of 20, 30, 50, 60, 100, 120 and 200 film-coated tablets and 50 x 1 film-coated tablets in PVC/PVdC - aluminium perforated unit dose blisters.
Slovenian: Velikosti pakiranj: 20, 30, 50, 60, 100, 120 in 200 filmsko obloženih tablet ter 50 x 1 filmsko obložena tableta v perforiranem pretisnem omotu iz PVC/PVdC-aluminija, za enkratni odmerek.
English: In paediatric patients (1 month to less than 4 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 116 patients and had a treatment duration of 5 days.
Slovenian: Pri pediatričnih bolnikih (od 1 meseca do manj kot 4. leta starosti) je bila učinkovitost levetiracetama dokazana v dvojno slepi, s placebom nadzorovani študiji, ki je vključevala 116 bolnikov in je trajala 5
English: Excipient with known effect: Each film-coated tablet contains 0.35 mg colouring agent sunset yellow (E110).
Slovenian: Pomožna snov z znanim učinkom: Ena filmsko obložena tableta vsebuje 0,35 mg barvila oranžno FCF (E110).
English: 500 to 1,000 mg once daily (2)
Slovenian: 500 do 1.000 mg enkrat na dan(2)
English: 72 x serum creatinine (mg/dl)
Slovenian: (x 0,85 za ženske) 72 x koncentracija kreatinina v serumu (mg/dl)
English: Levetiracetam Teva may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy.
Slovenian: Zdravilo Levetiracetam Teva lahko oslabi vašo sposobnost vožnje ali upravljanja z orodjem ali strojev,
English: The primary measure of effectiveness was the responder rate (percent of patients with ≥ 50 % reduction from baseline in average daily partial onset seizure frequency) assessed by a blinded central reader using a 48-hour video EEG.
Slovenian: Osnovno merilo učinkovitosti je bila stopnja odziva (odstotek bolnikov z ≥ 50 % znižanjem povprečnih pogostosti napadov parcialnega izvora na dan glede na začetne vrednosti), ki jo je na 48
English: Add-on therapy for infants aged from 1 month to less than 6 months
Slovenian: Dojenčki od 1 do manj kot 6 mesecev
English: For children 6 years and above, an oral solution should be used for doses under 250 mg, for doses not multiple of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets.
Slovenian: Za otroke, stare 6 let in več, se mora pri odmerkih, manjših od 250 mg, pri odmerkih, ki niso večkratniki od 250 mg in se zato priporočenega odmerjanja ne more doseči z večimi tabletami in pri bolnikih, ki ne morejo požirati tablet, uporabiti peroralno raztopino.
English: 7 to 14 mg/kg once daily (2) (4)
Slovenian: 7 do 14 mg/kg enkrat na dan (2) (4)
English: An oral solution is the preferred formulation for use in infants and children under the age of 6 years.
Slovenian: Farmacevtska oblika peroralna raztopina je najprimernejša za uporabo pri dojenčkih in otrocih, mlajših od 6 let.
English: A peri- and post-natal development study was performed in rats with levetiracetam doses of 70, 350 and 1800 mg/kg/day.
Slovenian: Peri- in postnatalno študijo razvoja so izvedli pri podganah z odmerki levetiracetama po 70, 350 in
English: Dosing adjustment for infants, children and adolescent patients weighing less than 50 kg with impaired renal function:
Slovenian: Prilagoditev odmerjanja pri dojenčkih, otrocih in mladostnikih s telesno maso, manjšo kot 50 kg, z okvarjenim delovanjem ledvic.
English: The cumulative urinary excretion of levetiracetam and its primary metabolite accounted for 66 % and 24 % of the dose, respectively during the first 48 hours.
Slovenian: Kumulativno se v prvih 48 urah z urinom izloči 66 % odmerka levetiracetama in 24 % odmerka njegovega primarnega presnovka.
English: How to take Levetiracetam Teva
Slovenian: Kako jemati zdravilo Levetiracetam Teva
English: Levetiracetam Teva are available in pack sizes of 20, 30, 50, 60, 100, 120 and 200 film-coated tablets and 50 x 1 film-coated tablets in PVC/PVdC - aluminium perforated unit dose blisters.
Slovenian: Filmsko obložene tablete zdravila Levetiracetam Teva so na voljo v pakiranjih po 20, 30, 50, 60, 100, 120 in 200 tablet ter 50 x 1 filmsko obložena tableta v perforiranem pretisnem omotu iz PVC/PVdCaluminija za enkratni odmerek.
English: The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily.
Slovenian: 25 kg, mora biti 250 mg dvakrat na dan z največjim odmerkom 750 mg dvakrat na dan.
English: (1)An oral solution should be used for doses under 250 mg, for doses not multiple of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets.
Slovenian: (1)Pri odmerkih manjših od 250 mg, pri odmerkih, ki niso večkratniki od 250 mg in se priporočenega odmerjanja zato ne more doseči z večimi tabletami in pri bolnikih, ki ne morejo požirati tablet, je treba uporabiti peroralno raztopino.
English: Take the number of tablets following your doctor's instructions.
Slovenian: Vzemite toliko tablet, kot vam je predpisal zdravnik.
English: This medicinal product contains colouring agent tartrazine (E102) which may cause allergic reactions.
Slovenian: Zdravilo vsebuje barvilo tartrazin (E102), ki lahko povzroči alergijske reakcije.
English: Co-administration with digoxin, oral contraceptives and warfarin did not influence the pharmacokinetics of levetiracetam.
Slovenian: Sočasna uporaba levetiracetama z digoksinom, s peroralnimi kontraceptivi in z varfarinom ni vplivala na njegovo farmakokinetiko.
English: What Levetiracetam Teva looks like and contents of the pack
Slovenian: Izgled zdravila Levetiracetam Teva in vsebina pakiranja
English: • severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction], Quincke's oedema [swelling of the face, lips, tongue and throat]);
Slovenian: • hude alergijske reakcije (DRESS, anafilaktična reakcija [huda in pomembna alergijska reakcija],
English: The recommended starting dose is 250 mg twice daily which should be increased to an initial therapeutic dose of 500 mg twice daily after two weeks.
Slovenian: Priporočeni začetni odmerek je 250 mg dvakrat na dan, ki ga po dveh tednih povečamo na začetni terapevtski odmerek 500 mg dvakrat na dan. Odmerek se lahko poveča za 250 mg dvakrat na dan vsaka dva tedna glede na klinični odziv.
English: Dose and frequency
Slovenian: odmerjanje in pogostnost normalno delovanje ledvic
English: A dose of 20 mg/kg/day titrating to 40 mg/kg/day for infants one month to less than six months and a dose of 25 mg/kg/day titrating to 50 mg/kg/day for infants and children 6 months to less than 4 years old, was use in this study.
Slovenian: V tej študiji so pri dojenčkih, od 1. meseca do manj kot 6 mesecev starosti, uporabljali odmerek 20 mg/kg/dan titriran do 40 mg/kg/dan, za dojenčke in otroke, od 6 mesecev do manj kot 4. leta starosti, pa odmerek 25 mg/kg/dan titriran do 50 mg/kg/dan.
English: Levetiracetam Teva 500 mg contains the colouring agent tartrazine (E102) that may cause allergic reactions.
Slovenian: Zdravilo Levetiracetam Teva 500 mg vsebuje barvilo tartrazin (E102), ki lahko povzroči alergijske reakcije.
English: Levetiracetam Teva is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Slovenian: Zdravilo Levetiracetam Teva je indicirano za samostojno zdravljenje napadov parcialnega izvora s sekundarno generalizacijo ali brez nje pri odraslih in mladostnikih od 16. leta starosti z na novo diagnosticirano epilepsijo.
English: Peak concentrations (Cmax) are typically 31 and 43 μg/ml following a single 1,000 mg dose and repeated 1,000 mg twice daily dose, respectively.
Slovenian: Po posamičnem 1000 mg odmerku je največja koncentracija (Cmax) po navadi 31 μg/ml, po ponavljajočih odmerkih 1000 mg dvakrat na dan pa 43 μg/ml.
English: Probenecid (500 mg four times daily), a renal tubular secretion blocking agent, has been shown to inhibit the renal clearance of the primary metabolite, but not of levetiracetam.
Slovenian: Probenecid Ugotovili so, da probenecid (500 mg štirikrat na dan), ki preprečuje ledvično tubularno sekrecijo,
English: How to store Levetiracetam Teva Contents of the pack and other information
Slovenian: 5 Shranjevanje zdravila Levetiracetam Teva Vsebina pakiranja in dodatne informacije
English: The CLcr in ml/min/1.73 m2 may be estimated from serum creatinine (mg/dl) determination, for young adolescents, children and infants, using the following formula (Schwartz formula):
Slovenian: CLcr v ml/min/1,73 m je pri mlajših mladostnikih, otrocih in dojenčkih, mogoče oceniti iz koncentracije kreatinina v serumu (mg/dl) z uporabo naslednje formule (po Schwartzevi formuli): CLcr (ml/min/1,73 m2 = Višina (cm) x ks koncentracija kreatinina v serumu (mg/dl)
English: With continued long-term treatment, 28.6 % of the patients were free of myoclonic seizures for at least 6 months and 21.0 % were free of myoclonic seizures for at least 1 year.
Slovenian: Z nadaljevanjem dolgotrajnega zdravljenja je bilo 28,6 % bolnikov brez miokloničnih napadov vsaj 6 mesecev, 21,0 % pa jih je bilo brez miokloničnih napadov vsaj 1 leto.
English: • A small number of people being treated with anti-epileptics such as Levetiracetam Teva have had thoughts of harming or killing themselves.
Slovenian: • pri majhnem številu bolnikov, ki so se zdravili z antiepileptiki kot je zdravilo Levetiracetam
English: Monotherapy for adults and adolescents from 16 years of age
Slovenian: Odmerjanje Samostojno zdravljenje za odrasle in mladostnike od 16. leta starosti:
English: In this study, levetiracetam, dose was 3000 mg/day given in 2 divided doses.
Slovenian: V tej študiji je bil odmerek levetiracetama 3000 mg na dan, razdeljen na dva odmerka.
English: The NOAEL was ≥ 1800 mg/kg/day for the F0 females, and for the survival, growth and development of the F1 offspring up to weaning (x 6 the MRHD on a mg/m2 basis).
Slovenian: Odmerek, pri katerem ni mogoče opaziti neželenih učinkov (NOAEL) je bil ≥1800 mg/kg/dan tako za F0 samice kot za preživetje, rast in razvoj F1 mladičev do prenehanja dojenja (6kratna vrednost največjega priporočenega odmerka pri ljudeh glede na mg/m2).
English: Levetiracetam Teva 750 mg contains the colouring agent sunset yellow (E110) that may cause allergic reactions.
Slovenian: Zdravilo Levetiracetam Teva 750 mg vsebuje barvilo oranžno FCF (E110), ki lahko povzroči alergijske reakcije.
English: An oral solution is a formulation more appropriate to infants and children under the age of 6 years and to children and adolescent (from 6 to 17 years) weighing less than 50 kg and when tablets don't allow accurate dosage.
Slovenian: Za dojenčke in otroke, mlajše od 6 let, za otroke in mladostnike (od 6 do 17 let), lažje od 50 kg in kadar s tabletami ne moremo zagotoviti natančnega odmerjanja, je peroralna raztopina primernejša farmacevtska oblika.
English: Rare: may affect up to 1 in 1,000 people • infection;
Slovenian: Redki: pojavijo se pri 1 od 1.000 oseb
English: The NOAEL was < 200 mg/kg/day for the dams and 200 mg/kg/day for the foetuses (equal to the MRHD on a mg/m2 basis).
Slovenian: Odmerek, pri katerem ni mogoče opaziti neželenih učinkov (NOAEL), je bil < 200 mg/kg/dan za samice in 200 mg/kg/dan za zarodke (je enako največjemu priporočenemu odmerku pri ljudeh glede na mg/m2.
English: Neonatal and juvenile animal studies in rats and dogs demonstrated that there were no adverse effects seen in any of the standard developmental or maturation endpoints at doses up to 1800 mg/kg/day (x 6 - 17 the MRHD on a mg/m2 basis).
Slovenian: V študijah pri novoskotenih živalih in mladičih živali so dokazali, da pri podganah in psih pri odmerkih do 1800 mg/kg/dan (6-kratna do 17-kratna vrednost največjega priporočenega odmerka pri ljudeh glede na mg/m2) ni bilo neželenih učinkov na standardne parametre razvoja in dozorevanja.
English: A double-blind, placebo-controlled paediatric safety study with a non-inferiority design has assessed the cognitive and neuropsychological effects of levetiracetam in children 4 to 16 years of age with partial onset seizures.
Slovenian: Dvojno slepa, s placebom nadzorovana pediatrična študija o varnosti z modelom o enakovrednosti zdravljenja je pokazala kognitivne in nevropsihološke učinke levetiracetama, pri pediatričnih bolnikih,
English: When you will first start taking Levetiracetam Teva, your doctor will prescribe you a lower dose (500 mg each day) during 2 weeks before giving you the lowest general dose of 1,000 mg.
Slovenian: Običajni odmerek: med 1000 mg in 3000 mg na dan. Na začetku jemanja zdravila Levetiracetam Teva vam bo zdravnik, preden vam bo predpisal najmanjši običajni odmerek 1000 mg, za dva tedna predpisal manjši odmerek (500 mg na dan).
English: The CLcr in ml/min may be estimated from serum creatinine (mg/dl) determination, for adults and adolescents weighting 50 kg or more, the following formula:
Slovenian: CLcr v ml/min je pri odraslih in mladostnikih, s telesno maso 50 kg in več, mogoče oceniti iz koncentracije kreatinina v serumu (mg/dl) po formuli: CLcr (ml/min) = [140-starost(leta)] x masa (kg)
English: Levetiracetam Teva 250 mg film-coated tablets Levetiracetam Teva 500 mg film-coated tablets Levetiracetam Teva 750 mg film-coated tablets Levetiracetam Teva 1000 mg film-coated tablets
Slovenian: Levetiracetam Teva 250 mg filmsko obložene tablete Levetiracetam Teva 500 mg filmsko obložene tablete Levetiracetam Teva 750 mg filmsko obložene tablete Levetiracetam Teva 1000 mg filmsko obložene tablete
English: Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
Slovenian: Dopolnilno zdravljenje primarno generaliziranih tonično-kloničnih napadov pri odraslih in mladostnikih od 12. leta starosti z idiopatsko generalizirano epilepsijo
English: Oral absolute bioavailability is close to
Slovenian: Absolutna biološka uporabnost peroralno uporabljenega zdravila je skoraj 100 %.
English: Levetiracetam Teva 250 mg film-coated tablets Levetiracetam Teva 500 mg film-coated tablets Levetiracetam Teva 750 mg film-coated tablets Levetiracetam Teva 1,000 mg film-coated tablets levetiracetam
Slovenian: Levetiracetam Teva 250 mg filmsko obložene tablete Levetiracetam Teva 500 mg filmsko obložene tablete Levetiracetam Teva 750 mg filmsko obložene tablete Levetiracetam Teva 1000 mg filmsko obložene tablete levetiracetam
English: Add-on therapy for infants aged 6 to 23 months, children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg
Slovenian: Dopolnilno zdravljenje za dojenčke, stare 6 do 23 mesecev, otroke (od 2 do 11 let) in mladostnike (od
English: Should your doctor decide to stop your Levetiracetam Teva treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam Teva.
Slovenian: Če se bo vaš zdravnik odločil za prekinitev zdravljenja z zdravilom Levetiracetam Teva,
English: 500 mg film-coated tablets: indigotine (E132), tartrazine (E102) and iron oxide yellow (E172).
Slovenian: 500 mg filmsko obložene tablete: indigotin (E132), tartrazin (E102) in rumeni železov oksid (E172)
English: Creatinine clearance (ml/min/1.73 m2)
Slovenian: (ml/min/1,73m2)
English: Tablet coating
Slovenian: Obloga tablete